|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 49, 349-357, February 2008 Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency1
* Lipid Clinic and Lipid Metabolism Laboratory, Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil 1 Presented in part on November 14, 2006, at the Council on Arteriosclerosis, Thrombosis, and Vascular Biology sessions at the annual meeting of the American Heart Association, Chicago, IL. Published, JLR Papers in Press, November 8, 2007.
2 To whom correspondence should be addressed. e-mail: raul.santos{at}incor.usp.br
Our aim was to characterize HDL subspecies and fat-soluble vitamin levels in a kindred with familial apolipoprotein A-I (apoA-I) deficiency. Sequencing of the APOA1 gene revealed a nonsense mutation at codon –2, Q[–2]X, with two documented homozygotes, eight heterozygotes, and two normal subjects in the kindred. Homozygotes presented markedly decreased HDL cholesterol levels, undetectable plasma apoA-1, tuboeruptive and planar xanthomas, mild corneal arcus and opacification, and severe premature coronary artery disease. In both homozygotes, analysis of HDL particles by two-dimensional gel electrophoresis revealed undetectable apoA-I, decreased amounts of small
Supplementary key words coronary heart disease high density lipoproteins fat soluble vitamins xanthomas atherosclerosis Abbreviations: apoA-I, apolipoprotein A-I; CETP, cholesteryl ester transfer protein; CHD, coronary heart disease; TRL, triglyceride-rich lipoprotein
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||